News

California's CARE Court aims to provide community-based behavioral health services to individuals with schizophrenia spectrum ...
Risperidone alters key brain regions in schizophrenia, with future imaging tools offering insights into its long-term effects ...
Digital health interventions (DHIs) show promise for the treatment of mental health disorders. However, existing ...
The Vanguard, a small nonprofit newsroom, is in need of $15,000 to stay afloat and pay its dedicated staff, and donations of ...
A new update, led by researchers at the UNC School of Medicine and the Gillings School of Global Public Health, describes ...
MapLight Therapeutics today announced the initiation of a Phase 2 study to evaluate the efficacy, safety and tolerability of ML-007C-MA, an investigational novel M1/M4 agonist, as a potential ...
Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as ...
A Court of King's Bench judge in Saskatoon says a man who fatally stabbed his girlfriend in 2022 is not criminally ...
Cobenfy Falls Short as Add-On Therapy for Schizophrenia Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a statistically ...
Nearly 150 laws went into effect in Florida on July 1, including a wide variety of new crimes, harsher penalties, and changes ...
Addex Therapeutics (SIX: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced ...